2025-01-15
Milestone! World's First Ovarian Dual Activation Technology Assists Patients in Conception
ecently, a major breakthrough in the field of reproductive health has garnered wide attention. The "ovarian dual activation" technology, collaboratively developed by the Yinfeng Life Sciences Research Institute (referred to as "Yinfeng Life Sciences") and the team of Professor Wang Huiying and Dr. Jin Bo from the Shenzhen Hospital of Beijing University of Chinese Medicine (referred to as "the hospital"), has achieved another milestone in cryobiomedical technology. Using methods of "cryopreservation + PFC", this technology has helped two patients achieve natural conception, providing new hope for women of childbearing age who are cancer patients, infertile, or of advanced maternal age.
2025-01-13
Robert Montgomery, the director of the NYU Langone Transplant Institute, stated in an interview, "This gives us more insight into the expectations for clinical trials, which can include patients with relatively good overall health."
2024-10-21
2024-10-12
Remember Captain America's century-spanning frozen wake-up in "The Avengers"? In reality, although we cannot replicate such a heroic legend, the scientific community is quietly unveiling the secrets of pausing life at an astonishing pace, exploring the infinite possibilities of the future.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155507
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
